Colorectal cancer follow-up: Useful or useless?

Surgical Oncology

Volumn 15, Issue 1, 2006, Pages 1-12

  Li Destri, Giovanni ^a   Di Cataldo, Antonio ^a   Puleo, Stefano ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Colorectal cancer; Costs; Follow up; Guidelines

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

BLOOD ANALYSIS; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL EXAMINATION; CLINICAL PRACTICE; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL CANCER; COLORECTAL SURGERY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; ENDOSCOPY; FOLLOW UP; HUMAN; LIVER METASTASIS; LUNG METASTASIS; META ANALYSIS; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RECURRENCE RISK; REVIEW; RISK ASSESSMENT; SURVIVAL TIME; SYSTEMATIC REVIEW; TREATMENT PLANNING;

CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; COST-BENEFIT ANALYSIS; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; NEOPLASM METASTASIS; RECURRENCE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33747884731     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suronc.2006.06.001     Document Type: Review

References (149)

1. Connor S., Frizelle F.A., and Bagshaw P.F. Follow-up after attempted curative surgery for colorectal cancer; postal survey of New Zealand surgeons' practice. New Zealand Medical Journal 114 1129 (2001) 151-153
2. Florey C.D.V., Yule B., Fogg A., Napier A., Orbell S., and Cuschieri A. A randomized trial of immediate discharge of surgical patients to general practice. Journal of Public Health Medicine 16 4 (1994) 455-464
3. Foster M.E., Hill J., and Leaper D.J. Follow-up after colo-rectal cancer. Current practice in Wales and south-west England. International Journal of Colorectal Dimension 2 2 (1987) 118-119
4. McArdle C. ABC of colorectal cancer: effectiveness of follow up. British Medical Journal 321 7272 (2000) 1332-1335
5. Mella J., Datta S.N., Biffin A., Radcliffe A.G., Steele R.J., and Stamatakis J.D. Surgeons' follow-up practice after resection of colorectal cancer. Annals of the Royal College of Surgeons of England 79 3 (1997) 206-209
6. Simpson H., Jeffery M., Hickey B., Frizelle F., and Frampton C. Postoperative follow-up strategies for patients after potentially curative surgery for colorectal cancer at Christchurch Hospital. New Zealand Medical Journal 117 1193 (2004) U873
7. Vernava III A.M., Longo W.E., Virgo K.S., Coplin M.A., Wade T.P., and Johnson F.E. Current follow-up strategies after resection of colon cancer. Results of a survey of members of the American Society of Colon and Rectal Surgeons. Diseases of the Colon and Rectum 37 6 (1994) 573-583
8. Earle C.C., Grunfeld E., Coyle D., Cripps M.C., and Stern H.S. Cancer physicians' attitudes toward colorectal cancer follow-up. Annals of Oncology 14 3 (2003) 400-405
9. Kievit J. Colorectal cancer follow-up: a reassessment of empirical evidence on effectiveness. European Journal of Surgical Oncology 26 4 (2000) 322-328
10. Evidence-based medicine. A new approach to teaching the practice of medicine. Evidence-Based Medicine Working Group. JAMA 268 17 (1992) 2420-2425
11. Lohr K.N. Guidelines for clinical practice: what they are and why they count. Journal of Law Medicine & Ethics 23 1 (1995) 49-56
12. Goldberg R.M., Fleming T.R., Tangen C.M., Moertel C.G., Macdonald J.S., Haller D.G., et al. Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Annals of Internal Medicine 129 1 (1998) 27-35
13. Anthony T., Fleming J.B., Bieligk S.C., Sarosi G.A., Kim L.T., Gregorcyk S.G., et al. Postoperative colorectal cancer surveillance. Journal of the American College of Surgeons 190 6 (2000) 737-749
14. Korner H., Soreide K., Stokkeland P.J., and Soreide J.A. Systematic follow-up after curative surgery for colorectal cancer in Norway: a population-based audit of effectiveness, costs, and compliance. Journal of Gastrointestinal Surgery 9 3 (2005) 320-328
15. Turk P.S., and Wanebo H.J. Results of surgical treatment of nonhepatic recurrence of colorectal carcinoma. Cancer 71 suppl. 12 (1993) 4267-4277
16. Anthony T., Simmang C., Hyman N., Buie D., Kim D., Cataldo P., et al. Standards Practice Task Force, The American Society of Colon and Rectal Surgeons. Practice parameters for the surveillance and follow-up of patients with colon and rectal cancer. Diseases of the Colon and Rectum 47 6 (2004) 807-817
17. Kjeldsen B.J., Thorsen H., Whalley D., and Kronborg O. Influence of follow-up on health-related quality of life after radical surgery for colorectal cancer. Scandinavian Journal of Gastroenterology 34 5 (1999) 509-515
18. Graham R.A., Wang S., Catalano P.J., and Haller D.G. Postsurgical surveillance of colon cancer: preliminary cost analysis of physician examination, carcinoembryonic antigen testing, chest X-ray, and colonoscopy. Annals of Surgery 228 1 (1998) 59-63
19. Figueredo A., Rumble R.B., Maroun J., Earle C.C., Cummings B., McLeod R., et al. Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care. Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care. Follow-up of patients with curatively colorectal cancer: a practice guideline. BMC Cancer 3 (2003) 26
20. Guthrie J.A. Colorectal cancer: follow-up and detection of recurrence. Abdominal Imaging 27 5 (2002) 570-577
21. Kronborg O. Colorectal cancer follow-up. European Journal of Surgical Oncology 26 4 (2000) 321
22. Norum J., and Olsen J.A. A cost-effectiveness approach to the Norwegian follow-up programme in colorectal cancer. Annals of Oncology 8 11 (1997) 1081-1087
23. Simpson H., Jeffery M., Hickey B., Frizelle F., and Frampton C. Postoperative follow-up strategies for patients after potentially curative surgery for colorectal cancer at Christchurch hospital. New Zealand Medical Journal 117 1193 (2004) U873
24. Meyerhardt J.A., and Mayer R.J. Follow-up strategies after curative resection of colorectal cancer. Seminars in Oncology 30 3 (2003) 349-360
25. Kievit J. Follow-up of patients with colorectal cancer; numbers needed to test and treat. European Journal of Cancer 38 7 (2002) 986-999
26. Secco G.B., Fardelli R., Giaquinto D., Bonfante P., Baldi E., Ravera G., et al. Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial. European Journal of Surgical Oncology 28 4 (2002) 418-423
27. Berman J.M., Cheung R.J., and Weinberg D.S. Surveillance after colorectal cancer resection. Lancet 355 9201 (2000) 395-399
28. Borie F., Combescure C., Daurès J.P., Trétarre B., and Millat B. Cost-effectiveness of two follow-up strategies for curative resection of colorectal cancer: comparative study using Markov model. World Journal of Surgery 28 6 (2004) 563-569
29. Scholefield J.H., and Steele R.J. Guidelines for follow up after resection of colorectal cancer. Gut 51 Suppl. 5 (2002) V3-V5
30. Staib L., Link K.H., and Beger H.G. Follow-up in colorectal cancer: cost-effectiveness analysis of established and novel concepts. Langenbecks Archives of Surgery 385 6 (2000) 412-420
31. Pfister D.G., Benson A.B., and Somerfield M.R. Clinical practice. Surveillance strategies after curative treatment of colorectal cancer. New England Journal of Medicine 350 23 (2004) 2375-2382
32. Cochrane J.P., Williams J.T., Faber R.G., and Slack W.W. Value of outpatient follow-up after curative surgery for carcinoma of the large bowel. British Medical Journal 280 6214 (1980) 593-595
33. Li Destri G., Craxi G., Rinzivillo C., Bonanno G., Di Cataldo A., Puleo S., et al. Colorectal follow-up. Our experience. Chirurgia 9 3 (1996) 261-267
34. Schoemaker D., Black R., Giles L., and Toouli J. Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients. Gastroenterology 114 1 (1998) 7-14
35. Camunas J., Enriquez J.M., Devesa J.M., Morales V., and Millan I. Value of follow-up in the management of recurrent colorectal cancer. European Journal of Surgical Oncology 17 5 (1991) 530-535
36. Desch C.E., Benson III A.B., Smith T.J., Flynn P.J., Krause C., Loprinzi C.L., et al. Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology. Journal of Clinical Oncology 17 4 (1999) 1312-1321
37. Audisio R.A., and Robertson C. Colorectal cancer follow-up: perspectives for future studies. European Journal of Surgical Oncology 26 4 (2000) 329-337
38. Steele Jr. G. Standard postoperative monitoring of patients after primary resection of colon and rectum cancer. Cancer 71 Suppl. 12 (1993) 4225-4235
39. Kievit J., and Bruinvels D. Detection of recurrence after surgery for colorectal cancer. European Journal of Cancer 31A 7-8 (1995) 1222-1225
40. Renehan A.G., Egger M., Saunders M.P., and O'Dwyer S.T. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ 324 7341 (2002) 813
41. Jeffery G.M., Hickey B.E., and Hider P. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database System Review 1 (2002) CD002200
42. Rosen M., Chan L., Beart R.W., Vukasin P., and Anthone G. Follow-up of colorectal cancer: a meta-analysis. Diseases of the Colon and Rectum 41 9 (1998) 1116-1126
43. Bruinvels D.J., Stiggelbout A.M., Kievit J., van Houwelingen H.C., Habbema J.D., and van de Velde C.J. Follow-up of patients with colorectal cancer. A meta-analysis. Annals of Surgery 219 2 (1994) 174-182
44. Ohlsson B., Breland U., Ekberg H., Graffner H., and Tranberg K.G. Follow-up after curative surgery for colorectal carcinoma. Randomised comparison with no follow-up. Diseases of the Colon and Rectum 38 6 (1995) 619-626
45. Pietra N., Sarli L., Costi R., Ouchemi C., Grattarola M., and Peracchia A. Role of follow-up in management of local recurrence of colorectal cancer. Diseases of the Colon and Rectum 41 9 (1998) 1127-1133
46. Kjeldsen B.J., Kronborg O., Fenger C., and Jorgensen O.D. A prospective randomized study of follow-up after radical surgery for colorectal cancer. British Journal of Surgery 84 5 (1997) 666-669
47. Makela J.T., Laitinen S.O., and Kairaluoma M.I. Five-year follow-up after radical surgery for colorectal cancer. Results of a prospective randomized trial. Archives of Surgery 130 10 (1995) 1062-1067
48. Renehan A.G., Egger M., Saunders M.P., and O'Dwyer S.T. Mechanisms of improved survival from intensive follow-up in colorectal cancer: a hypothesis. British Journal of Cancer 92 3 (2005) 430-433
49. Giovagnoni A., Ottaviani L., Mensa A., Durastanti M., Floriani I., and Cascinu S. Evidence Based Medicine (EBM) and Evidence Based Radiology (EBR) in the follow-up of the patients after surgery for lung and colon-rectal carcinoma. Radiol Med (Torino) 109 4 (2005) 345-357
50. Hookman P., and Barkin J.S. The role of vigorous detection of recurrence after curative resection of colorectal cancer. American Journal of Gastroenterology 93 12 (1998) 2624-2627
51. LeLorier J., Gregoire G., Benhaddad A., Lapierre J., and Derderian F. Discrepancies between meta-analyses and subsequent large randomized, controlled trials. New England Journal of Medicine 337 8 (1997) 536-542
52. Hohenberger P. Colorectal cancer-what is standard surgery?. European Journal of Cancer 37 Suppl. 7 (2001) S173-S187
53. Soybel D.I. Careful follow-up for patients undergoing curative resections in colorectal carcinoma: how careful is "careful"?. Gastroenterology 114 1 (1998) 220-221
54. Chau I., Allen M.J., Cunningham D., Norman A.R., Brown G., Ford H.E., et al. The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer. Journal of Clinical Oncology 22 8 (2004) 1420-1429
55. Ohlsson B., and Palsson B. Follow-up after colorectal cancer surgery. Acta Oncologica 42 8 (2003) 816-826
56. Nordic Gastrointestinal Tumor Adjuvant Therapy Group. Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial. Journal of Clinical Oncology 10 6 (1992) 904-911
57. Rougier P., and Lepere C. Metastatic colorectal cancer: first- and second-line treatment in 2005. Seminars in Oncology 32 6 Suppl. 8 (2005) 15-20
58. Saltz L.B. Metastatic colorectal cancer: is there one standard approach?. Oncology (Williston Park) 19 9 (2005) 1147-1154
59. Venook A. Critical evaluation of current treatments in metastatic colorectal cancer. Oncologist 10 4 (2005) 250-261
60. Braun A.H., Achterrath W., Wilke H., Vanhoefer U., Harstrick A., and Preusser P. New systemic frontline treatment for metastatic colorectal carcinoma. Cancer 100 8 (2004) 1558-1577
61. Christopoulou A. Chemotherapy in metastatic colorectal cancer. Techniques in Coloproctology 8 Suppl. 1 (2004) s43-s46
62. Damjanovic D., Thompson P., and Findlay M.P. Evidence-based update of chemotherapy options for metastatic colorectal cancer. ANZ Journal of Surgery 74 9 (2004) 781-787
63. Hoff P.M., and Pazdur R. Progress in the development of novel treatments for colorectal cancer. Oncology (Williston Park) 18 6 (2004) 705-708
64. Kohne C.H., Bruce C., Folprecht G., and Audisio R. Role of new agents in the treatment of colorectal cancer. Surgical Oncology-Oxford 13 2-3 (2004) 75-81
65. Park D.J., Stoehlmacher J., and Lenz H.J. Tailoring chemotherapy in advanced colorectal cancer. Current Opinion in Pharmacology 3 4 (2003) 378-385
66. Coutinho A.K., and Rocha Lima C.M. Metastatic colorectal cancer: systemic treatment in the new millennium. Cancer Control 10 3 (2003) 224-238
67. Van Cutsem E., Verslype C., and Demedts I. The treatment of advanced colorectal cancer: where are we now and where do we go?. Best Practice & Research in Clinical Gastroenterology 16 2 (2002) 319-330
68. Peethambaram P., Weiss M., Loprinzi C.L., Novotny P., O'Fallon J.R., Erlichman C., et al. An evaluation of postoperative follow-up tests in colon cancer patients treated for cure. Oncology 54 4 (1997) 287-292
69. Li Destri G., Rinzivillo C., Craxi G., La Greca G., Di Cataldo A., Puleo S., et al. Colorectal follow-up planning modified on the basis of our personal experience. Digestive Surgery 15 1 (1998) 64-68
70. Li Destri G., Sgroi A., Di Cataldo A., Puleo S., Minutolo V., and Licata A. Rectal cancer: a follow-up planned on the basis of the acquired experience. Journal of Tumor Marker Oncology 18 (2003) 153-159
71. Sugarbaker P.H., Gianola F.J., Dwyer A., and Neuman N.R. A simplified plan for follow-up of patients with colon and rectal cancer supported by prospective studies of laboratory and radiologic test results. Surgery 102 1 (1987) 79-87
72. Northover J. Realism or nihilism in bowel cancer follow-up?. Lancet 351 9109 (1998) 1074-1076
73. Boulin M., Lejeune C., Le Teuff G., Binquet C., Bouvier A.M., Bedenne L., et al. Patterns of surveillance practices after curative surgery for colorectal cancer in a French population. Diseases of the Colon and Rectum 48 10 (2005) 1890-1899
74. Li Destri G., Sapienza S., Rodolico M., Di Cataldo A., Puleo S., Minutolo V., et al. Stress of routine follow-up in colorectal cancer operated patients. Chirurgia Italiana 52 6 (2000) 695-698
75. Papagrigoriadis S., and Heyman B. Patients' views on follow up of colorectal cancer: implications for risk communication and decision making. Postgraduate Medical Journal 79 933 (2003) 403-407
76. Stiggelbout A.M., de Haes J.C., Vree R., van de Velde C.J., Bruijninckx C.M., van Groningen K., et al. Follow-up of colorectal cancer patients: quality of life and attitudes towards follow-up. British Journal of Cancer 75 6 (1997) 914-920
77. Kiebert G.M., Welvaart K., and Kievit J. Psychological effects of routine follow up on cancer patients after surgery. European Journal of Surgery 159 11-12 (1993) 601-607
78. Kuchler T., Henne-Bruns D., Rappat S., Graul J., Holst K., Williams J.I., et al. Impact of psychotherapeutic support on gastrointestinal cancer patients undergoing surgery: survival results of a trial. Hepatogastroenterology 46 25 (1999) 322-335
79. Nordin K., and Glimelius B. Psychological reactions in newly diagnosed gastrointestinal cancer patients. Acta Oncologica 36 8 (1997) 803-810
80. Rocklin M.S., Senagore A.J., and Talbott T.M. Role of carcinoembryonic antigen and liver function tests in the detection of recurrent colorectal carcinoma. Diseases of the Colon and Rectum 34 9 (1991) 794-797
81. Kronborg O. Optimal follow-up in colorectal cancer patients: what tests and how often?. Seminars in Surgical Oncology 10 3 (1994) 217-224
82. Virgo K.S., Wade T.P., Longo W.E., Coplin M.A., Vernava A.M., and Johnson F.E. Surveillance after curative colon cancer resection: practice patterns of surgical subspecialists. Annals of Surgical Oncology 2 6 (1995) 472-482
83. Benson III A.B., Desch C.E., Flynn P.J., Krause C., Loprinzi C.L., Minsky B.D., et al. American Society of Clinical Oncology. 2000 update of American Society of Clinical Oncology colorectal cancer surveillance guidelines. Journal of Clinical Oncology 18 20 (2000) 3586-3588
84. McCall J.L., Black R.B., Rich C.A., Harvey J.R., Baker R.A., Watts J.M., et al. The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer. Diseases of the Colon and Rectum 37 9 (1994) 875-881
85. Moertel C.G., Fleming T.R., Macdonald J.S., Haller D.G., Laurie J.A., and Tangen C. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA 270 8 (1993) 943-947
86. Li Destri G., Greco S., Rinzivillo C., Racalbuto A., Curreri R., and Di Cataldo A. Monitoring carcinoembryonic antigen in colorectal cancer: is it still useful?. Surgery Today 28 12 (1998) 1233-1236
87. Child P.W., Yan T.D., Perera D.S., and Morris D.L. Surveillance-detected hepatic metastases from colorectal cancer had a survival advantage in seven-year follow-up. Diseases of the Colon and Rectum 48 4 (2005) 744-748
88. Zeng Z., Cohen A.M., and Urmacher C. Usefulness of carcinoembryonic antigen monitoring despite normal preoperative values in node-positive colon cancer patients. Diseases of the Colon and Rectum 36 11 (1993) 1063-1068
89. Scheele J., Stangl R., Altendorf-Hofmann A., and Gall F.P. Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 110 1 (1991) 13-29
90. Fong Y., Cohen A.M., Fortner J.G., Enker W.E., Turnbull A.D., Coit D.G., et al. Liver resection for colorectal metastases. Journal of Clinical Oncology 15 3 (1997) 938-946
91. Inoue M., Ohta M., Iuchi K., Matsumura A., Ideguchi K., Yasumitsu T., et al. Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma. Annals of Thoracic Surgery 78 1 (2004) 238-244
92. Minton J.P., Hoehn J.L., Gerber D.M., Horsley J.S., Connolly D.P., Salwan F., et al. Results of a 400-patient carcinoembryonic antigen second-look colorectal cancer study. Cancer 55 6 (1985) 1284-1290
93. Northover J. Follow-up after curative surgery for colorectal cancer. Scandinavian Journal of Surgery 92 1 (2003) 84-89
94. Safi F., and Beyer H.G. The value of follow-up after curative surgery of colorectal carcinoma. Cancer Detection and Prevention 17 3 (1993) 417-424
95. Fletcher R.H. Carcinoembryonic antigen. Annals of Internal Medicine 104 1 (1986) 66-73
96. Sugihara K., and Yamamoto J. Surgical treatment of colorectal liver metastases. Annales Chirurgiae et Gynaecologiae 89 3 (2000) 221-224
97. Penna C., and Nordlinger B. Colorectal metastasis (liver and lung). Surgical Clinics of North America 82 5 (2002) 1075-1090
98. Ballantyne G.H., and Quin J. Surgical treatment of liver metastases in patients with colorectal cancer. Cancer 71 Suppl. 12 (1993) 4252-4266
99. Kinkel K., Lu Y., Both M., Warren R.S., and Thoeni R.F. Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. Radiology 224 3 (2002) 748-756
100. Scott D.J., Guthrie J.A., Arnold P., Ward J., Atchley J., Wilson D., et al. Dual phase helical CT versus portal venous phase CT for the detection of colorectal liver metastases: correlation with intra-operative sonography, surgical and pathological findings. Clinical Radiology 56 3 (2001) 235-242
101. Ntinas A., Zambas N., Al Mogrambi S., Petras P., Chalvatzoulis E., Frangandreas G., et al. Postoperative follow-up of patients with colorectal cancer: a combined evaluation of CT scan, colonoscopy and tumour markers. Techniques in Coloproctology 8 Suppl. 1 (2004) S190-S192
102. Glover C., Douse P., Kane P., Karani J., Meire H., Mohammadtaghi S., et al. Accuracy of investigations for asymptomatic colorectal liver metastases. Diseases of the Colon and Rectum 45 4 (2002) 476-484
103. Wernecke K., Rummeny E., Bongartz G., Vassallo P., Kivelitz D., Wiesmann W., et al. Detection of hepatic masses in patients with carcinoma: comparative sensitivities of sonography, CT, and MR imaging. AJR American Journal of Roentgenology 157 4 (1991) 731-739
104. Finlay I.G., Meek D., Brunton F., and McArdle C.S. Growth rate of hepatic metastases in colorectal carcinoma. British Journal of Surgery 75 7 (1988) 641-644
105. De Salvo L., Razzetta F., Arezzo A., Tassone U., Bogliolo G., Bruzzone D., et al. Surveillance after colorectal cancer surgery. European Journal of Surgical Oncology 23 6 (1997) 522-525
106. Howell J.D., Wotherspoon H., Leen E., Cooke T.C., and McArdle C.S. Evaluation of a follow-up programme after curative resection for colorectal cancer. British Journal of Cancer 79 2 (1999) 308-310
107. Adam R., Avisar E., Ariche A., Giachetti S., Azoulay D., Castaing D., et al. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Annals of Surgical Oncology 8 4 (2001) 347-353
108. Goldberg R.M., Sargent D.J., Morton R.F., Fuchs C.S., Ramanathan R.K., Williamson S.K., et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. Journal of Clinical Oncology 22 1 (2004) 23-30
109. Allen-Mersh T.G., Earlam S., Fordy C., Abrams K., and Houghton J. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet 344 8932 (1994) 1255-1260
110. Smith T.J., and Bear H.D. Standard follow-up of colorectal cancer patients: finally, we can make practice guidelines based on evidence. Gastroenterology 114 1 (1998) 211-213
111. Barkin J.S., Cohen M.E., Flaxman M., Lindblad A.S., Mayer R.J., Kalser M.H., et al. Value of a routine follow-up endoscopy program for the detection of recurrent colorectal carcinoma. American Journal of Gastroenterology 83 12 (1988) 1355-1360
112. Delpero J.R., Pol B., Le Treut P., Bardou V.J., Moutardier V., Hardwigsen J., et al. Surgical resection of locally recurrent colorectal adenocarcinoma. British Journal of Surgery 85 3 (1998) 372-376
113. Roncucci L. Local recurrences of rectal cancer. Minerva Chirurgica 60 3 (2005) 167-178
114. Fleischer D.E., Goldberg S.B., and Browning T.H. Detection and surveillance of colorectal cancer. JAMA 261 4 (1989) 580-585
115. Audisio R., Setti-Carraro P., Segala M., Capko D., Androni B., and Tiberio G. Follow-up in colorectal cancer patients: a cost-benefit analysis. Annals of Surgical Oncology 3 4 (1996) 349-357
116. Romano G., Belli G., and Rotondano G. Colorectal cancer. Diagnosis of recurrence. Gastrointestinal Endoscopy Clinics of North America 5 4 (1995) 831-841
117. Hunerbein M., Totkas S., Moesta K.T., Ulmer C., Handke T., and Schlag P.M. The role of transrectal ultrasound-guided biopsy in the postoperative follow-up of patients with rectal cancer. Surgery 129 2 (2001) 164-169
118. Kanyari Z., Orosz L., Juhasz B., Tanyi M., Nemeth E., Tron L., et al. The role of positron emission tomography (PET) in the detection of local recurrence and metastases of colorectal cancer. Magyar Sebeszet 58 3 (2005) 179-183
119. Lamy P.J., Comte F., and Eberle M.C. Combined role of tumor markers and 18fluoro-deoxyglucose-positron emission tomography (18FDG-PET) in follow-up of cancer patients. Bulletin du Cancer 92 10 (2005) 858-864
120. Liu F.Y., Chen J.S., Changchien C.R., Yeh C.Y., Liu S.H., Ho K.C., et al. Utility of 2-fluoro-2-deoxy-d-glucose positron emission tomography in managing patients of colorectal cancer with unexplained carcinoembryonic antigen elevation at different levels. Diseases of the Colon and Rectum 48 10 (2005) 1900-1912
121. Kim J.H., Czernin J., Allen-Auerbach M.S., Halpern B.S., Fueger B.J., Hecht J.R., et al. Comparison between 18F-FDG PET, in-line PET/CT, and software fusion for restaging of recurrent colorectal cancer. Journal of Nuclear Medicine 46 4 (2005) 587-595
122. Borrego Dorado I., Gomez Camarero P., Ruiz Franco-Baux J., and Vazquez Albertino R. Evaluation of efficacy and clinical impact of FDG-PET in patients with suspicion of recurrent colorectal cancer. Revista espanola de Medicina Nuclear 23 5 (2004) 313-323
123. Kula Z., Szefer J., Zuchora Z., Romanowicz G., and Pietrzak T. Evaluation of positron emission tomography by using F-18-fluorodeoxyglucose in diagnosis of recurrent colorectal cancer. Polski Merkuriusz Lekarski 17 Suppl. 1 (2004) 63-66
124. Rosa F., Meimarakis G., Stahl A., Bumm R., Hahn K., Tatsch K., et al. Colorectal cancer patients before resection of hepatic metastases. Impact of (18)F-FDG PET on detecting extrahepatic disease. Nuklearmedizin 43 4 (2004) 135-140
125. Selzner M., Hany T.F., Wildbrett P., McCormack L., Kadry Z., and Clavien P.A. Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver?. Annals of Surgery 240 6 (2004) 1027-1034
126. Wiering B., Ruers T.J., and Oyen W.J. Role of FDG-PET in the diagnosis and treatment of colorectal liver metastases. Expert Review of Anticancer Therapy 4 4 (2004) 607-613
127. Dimitrakopoulou-Strauss A., Strauss L.G., and Rudi J. PET-FDG as predictor of therapy response in patients with colorectal carcinoma. Quarterly Journal of Nuclear Medicine 47 1 (2003) 8-13
128. Lan Y.T., Lin J.K., Li A.F., Lin T.C., Chen W.S., Jiang J.K., et al. Metachronous colorectal cancer: necessity of post-operative colonoscopic surveillance. International Journal of Colorectal Disease 20 2 (2005) 121-125
129. Fajobi O., Yiu C.Y., Sen-Gupta S.B., and Boulos P.B. Metachronous colorectal cancers. British Journal of Surgery 85 7 (1998) 897-901
130. Chen F., and Stuart M. Colonoscopic follow-up of colorectal carcinoma. Diseases of the Colon and Rectum 37 6 (1994) 568-572
131. Winawer S.J., Zauber A.G., Ho M.N., O'Brien M.J., Gottlieb L.S., Sternberg S.S., et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. New England Journal of Medicine 329 27 (1993) 1977-1981
132. McCormack P.M., and Ginsberg R.J. Current management of colorectal metastases to lung. Chest Surgical Clinics of North America 8 1 (1998) 119-126
133. Inoue M., Kotake Y., Nakagawa K., Fujiwara K., Fukuhara K., and Yasumitsu T. Surgery for pulmonary metastases from colorectal carcinoma. Annals of Thoracic Surgery 70 2 (2000) 380-383
134. McAfee M.K., Allen M.S., Trastek V.F., Ilstrup D.M., Deschamps C., and Pairolero P.C. Colorectal lung metastases: results of surgical excision. Annals of Thoracic Surgery 53 5 (1992) 780-785
135. Desch C.E., Benson III A.B., Somerfield M.R., Flynn P.J., Krause C., Loprinzi C.L., et al. American Society of Clinical Oncology. American Society of Clinical Oncology. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. Journal of Clinical Oncology 23 33 (2005) 8512-8519
136. Engstrom P. Update: NCCN colon cancer clinical practice guidelines. Journal of the National Comprehensive Cancer Network: JNCCN 3 Suppl. 1 (2005) S25-S28
137. Benson III A.B., Choti M.A., Cohen A.M., Doroshow J.H., Fuchs C., Kiel K., et al. National Comprehensive Cancer Network. NCCN Practice Guidelines for Colorectal Cancer. Oncology 14 11A (2000) 203-212
138. Van Cutsem E.J., and Kataja V.V. ESMO Guidelines Task Force. ESMO Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of colon cancer. Annals of Oncology 16 Suppl. 1 (2005) i16-i17
139. Tveit K.M., and Kataja V.V. ESMO Guidelines Task Force. ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of rectal cancer. Annals of Oncology 16 Suppl. 1 (2005) i20-i21
140. Hermanek P., Junginger T., Hossfeld D.K., Muller R.P., and Folsch U.R. Follow-up and rehabilitation for patients with gastrointestinal tumors. Dtsch Arztebl 96 (1999) A2084-A2088
141. Johnson F.E., Longo W.E., Vernava A.M., Wade T.P., Coplin M.A., and Virgo K.S. How tumor stage affects surgeons' surveillance strategies after colon cancer surgery. Cancer 76 8 (1995) 1325-1329
142. Yamamoto S., Akasu T., Fujita S., and Moriya Y. Postsurgical surveillance for recurrence of UICC stage I colorectal carcinoma: is follow-up by CEA justified?. Hepatogastroenterology 52 62 (2005) 444-449
143. Hughes K.S., Simon R., Songhorabodi S., Adson M.A., Ilstrup D.M., Fortner J.G., et al. Resection of the liver for colorectal metastases: a multi-institutional study of indicators for resection. Surgery 100 2 (1986) 278-284
144. Virgo K.S., Vernava A.M., Longo W.E., McKirgan L.W., and Johnson F.E. Cost of patient follow-up after potentially curative colorectal cancer treatment. JAMA 273 23 (1995) 1837-1841
145. Epstein R.J. Does the breast cancer dollar make sense?. European Journal of Cancer 28 2-3 (1992) 486-491
146. Arndt V., Merx H., Stegmaier C., Ziegler H., and Brenner H. Quality of life in patients with colorectal cancer 1 year after diagnosis compared with the general population: a population-based study. Journal of Clinical Oncology 22 23 (2004) 4829-4836
147. Earle C.C., Chapman R.H., Baker C.S., Bell C.M., Stone P.W., Sandberg E.A., et al. Systematic overview of cost-utility assessments in oncology. Journal of Clinical Oncology 18 18 (2000) 3302-3317
148. Michel P., Merle V., Chiron A., Ducrotte P., Paillot B., Hecketsweiler P., et al. Postoperative management of stage II/III colon cancer: a decision analysis. Gastroenterology 117 4 (1999) 784-793
149. Pignone M., Saha S., Hoerger T., and Mandelblatt J. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the US Preventive Services Task Force. Annals of Internal Medicine 137 2 (2002) 96-104